None listed
Conditions
Brief summary
This is a prospective observational multi-centre registry in which clinical data on consecutive patients with prostate cancer who undergo irreversible electroporation (IRE) procedure is collected. Who is it for? You may be eligible to join this study if you have been diagnosed with histologically confirmed prostate cancer and are scheduled for IRE Nanoknife procedure. Study details Patients with prostate cancer who undergo IRE procedure at participating clinics will have their medical data collected and collated into this clinical registry. Patients’ data to include baseline visit (pre-IRE) and peri-operative data. Participants will then be followed-up at 1, 3, 5, and 10 years after IRE to determine oncological and functional outcomes. Follow up data at each participating treatment site is collected according to the guidelines for focal therapy in prostate cancer and/or by discretion of each treating Urologist. Amendments to the standard of care are not required nor desirable. Deviation from current practices will be by the discretion of the treating urologist only and outcomes will be included in this registry as it is purely observational in nature. It is hoped that this research project will provide a better understanding of patient outcomes undergoing IRE procedure. .
Interventions
This is a prospective observational multi-centre registry in which clinical data on consecutive patients with prostate cancer who undergo IRE procedure is collected. Data from site medical records as part of standard of care will be collected at each participating site over a 10-year period. Patients’ data to include, baseline visit (pre-IRE), peri-operative data and follow up for 10 years will be recorded.
Follow up data at each participating treatment site is collected according to the guidel
This is a prospective observational multi-centre registry in which clinical data on consecutive patients with prostate cancer who undergo IRE procedure is collected. Data from site medical records as part of standard of care will be collected at each participating site over a 10-year period. Patients’ data to include, baseline visit (pre-IRE), peri-operative data and follow up for 10 years will be recorded. Follow up data at each participating treatment site is collected according to the guidelines for focal therapy in prostate cancer and/or by discretion of each treating Urologist. Amendments to the standard of care are not required nor desirable. Deviation from current practices will be by the discretion of the treating urologist only and outcomes will be included in this registry as it is purely observational in nature.
Sponsors
St Vincent's Private Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patient 18 years and above Is diagnosed with histologically confirmed prostate cancer Is scheduled for IRE Nanoknife® regardless of previous treatments
Exclusion criteria
No specific exclusion criteria are defined.
Outcome results
None listed